ExodusPoint Capital Management LP Buys Shares of 296,395 Corteva, Inc. $CTVA

ExodusPoint Capital Management LP bought a new stake in Corteva, Inc. (NYSE:CTVA) in the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 296,395 shares of the company’s stock, valued at approximately $19,867,000.

Other institutional investors also recently bought and sold shares of the company. JPL Wealth Management LLC purchased a new position in shares of Corteva in the 3rd quarter valued at about $25,000. Bank of Jackson Hole Trust purchased a new position in shares of Corteva in the 4th quarter valued at about $28,000. Redmont Wealth Advisors LLC purchased a new position in shares of Corteva in the 3rd quarter valued at about $29,000. Cornerstone Financial Management LLC purchased a new position in shares of Corteva in the 4th quarter valued at about $29,000. Finally, Basepoint Wealth LLC purchased a new position in shares of Corteva in the 4th quarter valued at about $30,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Price Performance

Shares of NYSE CTVA opened at $76.84 on Wednesday. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a twelve month low of $60.53 and a twelve month high of $85.63. The stock has a 50 day moving average of $80.02 and a two-hundred day moving average of $75.52. The stock has a market cap of $51.39 billion, a P/E ratio of 45.20, a P/E/G ratio of 2.32 and a beta of 0.57.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same quarter in the previous year, the business earned $1.13 earnings per share. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were paid a $0.18 dividend. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s payout ratio is currently 42.35%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. BNP Paribas Exane lifted their price objective on Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Barclays lifted their price objective on Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research note on Thursday, June 11th. Deutsche Bank Aktiengesellschaft lifted their price objective on Corteva from $90.00 to $100.00 in a research note on Monday, May 11th. Mizuho lifted their price objective on Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a research note on Wednesday, April 15th. Finally, Royal Bank Of Canada lifted their price objective on Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a research note on Thursday, May 7th. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $88.81.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.